RxDoctor Payments Data

Victoria Deanda

Adult Health · Grand Prairie, TXNPI 1710482427

Payments from drug & device makers

$2,300in general payments, 2019–2025

Across 112 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$454
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$231
  • AbbVie$176
  • Novartis$157
  • AstraZeneca$143
  • Pfizer$128
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,300100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,300 in reported general payments places this provider in the 75th percentile of 933 adult health providers in Texas.

See all adult health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$33,219
MounjaroTirzepatide13$13,981
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$7,358
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$4,732
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$4,353
Diclofenac Sodium76$3,604
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm21$3,400
Albuterol Sulfate HfaAlbuterol Sulfate98$2,596
Solifenacin Succinate26$2,009
Pregabalin26$2,004
Levocetirizine Dihydrochloride62$1,880
Gabapentin142$1,856
Losartan Potassium196$1,699
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm15$1,559
Rosuvastatin Calcium118$1,526

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$92$33,21926 claims
Lilly USA, LLCMounjaro, Humulin 70-30$57$15,41524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 933 adult health providers in Texas.

Other adult health in Grand Prairie

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →